Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer. Li BT, Smit EF, Goto Y, Nakagawa K, et al. N Engl J Med 2021 Sep 18. doi: 10.1056/NEJMoa2112431.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li BT, Smit EF, Goto Y, Nakagawa K, et al. Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer. N Engl J Med 2021 Sep 18. doi: 10.1056/NEJMoa2112431.
PMID: 34534430